FREDERICK, Md. and PLANO, Texas, Oct. 6, 2025 — RoosterBio Inc., a leading supplier of human mesenchymal stem/stromal cells (MSCs), highly engineered media, and bioprocess development services, and Secretome Therapeutics, a clinic-stage company developing novel therapies derived from neonatal cardiac progenitor cells (nCPC), today announced completion of commercial scale production of Secretome’s lead nCPC, STM-01. [Read more…]
Cord Blood vs. Cord Tissue Stem Cells: What are the Differences?
There are cells contained within a newborn’s umbilical cord blood and cord tissue that can be collected and stored for potential medical use. In this article, we explore the differences between these valuable cell types and how they may be used within the growing field of regenerative medicine (RM).
Read on to learn about the differences and potential uses of umbilical cord blood versus cord tissue stem cells.
In this article:
Stem Cell Therapy for Neuropathy: Take Your Pain Away
As the body ages, some of its processes gradually break down. This is often due to the fact that nerves in our extremities grow less sensitive over time, transmitting messages to the brain more slowly and feeling less acutely – a condition known as peripheral neuropathy or simply neuropathy.
While some of that is normal, especially in the golden years, neuropathy often manifests in people much too young – in their 30s, 40s, or 50s – as a result of a disease such as diabetes or autoimmune issues. Unfortunately, the condition can significantly hamper your quality of life, making mobility difficult and limiting everyday activities.
The good news? Neuropathy may have a cure, or at least a solid treatment, on the horizon. Stem cells show great promise for a wide variety of conditions, and nerve damage is the latest of these. To see how it can help, it’s important to understand what stem cell treatment is, what neuropathy is and how it could potentially be remedied.
In this article:
MSCs, the Latest Weapon Being Leveraged in Regenerative Medicine (RM)
Mesenchymal stem cells (MSCs) are multipotent cells that can differentiate into a variety of cell types, including but not limited to osteoblasts, chondrocytes, myocytes, and adipocytes. In addition to secreting factors that can stimulate tissue repair, MSCs can substantially alter their microenvironment, exerting effects that are both anti-inflammatory and anti-fibrotic. MSCs are advantageous over other stem cells types for a variety of reasons, including that they are immuno-privileged, making them an advantageous cell type for allogenic transplantation. [Read more…]
Cell Therapy Industry News Round-Up: November 2, 2025
The Cell and Gene Therapy Industry Accelerates with New Financing, Partnerships, and Clinical Milestones
The cell and gene therapy (CGT) sector is entering the final quarter of 2025 with remarkable momentum, driven by major financing rounds, strategic partnerships, manufacturing advances, and promising clinical data. Collectively, these developments highlight a sector that continues to mature, moving from scientific promise to commercial and clinical reality. [Read more…]
- « Previous Page
- 1
- …
- 44
- 45
- 46
- 47
- 48
- …
- 340
- Next Page »